Tirzepatide

Description

Tirzepatide

Category: Metabolic / Weight Management Research
Brand: NUVION™

Description:
Tirzepatide is a synthetic dual incretin receptor agonist that targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It has been the subject of extensive research for its potential to regulate glucose metabolism, enhance insulin sensitivity, and promote body weight reduction in controlled experimental settings. Scientific investigations suggest that Tirzepatide may influence multiple metabolic pathways involved in energy balance, lipid utilization, and appetite regulation.

At NUVION™, each vial of Tirzepatide is produced under rigorous GMP-compliant manufacturing standards to ensure exceptional purity, reproducibility, and stability. The peptide is lyophilized to maintain structural integrity and long-term bioactivity throughout research and storage.

Key Features:

• Dual GIP and GLP-1 receptor agonist (research-grade)
• 99%+ purity verified by HPLC
• Manufactured in a GMP-certified facility
• Lyophilized for superior preservation and stability
• Packaged and bottled in the USA from globally sourced ingredients

Intended Use:
For laboratory research only. Not for human consumption, injection, or diagnostic use.